drugset / Trial / NCT00440804

Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA

NCT00440804

Phase 3 Completed Farmacon
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of ibuprofen l-lysine iv in premature infants in the early treatment of Patent Ductus Arteriosus.

Timeline

Start
2002-12
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule Intravenous